I read an online article today from Benzinga, a financial media company that empowers its readers with daily actionable market analysis and commentary.  It reported on a new ADHD drug that the FDA had just approved, called Cotempla XR-OTD, a methylphenidate extended release orally-disintegrating tablet for treating ADHD in kids aged 6-17.  According to BMO...Read More

A new study of Scottish children published in the JAMA Pediatrics this week, suggests that the 1.0% of subjects (N= 7413) that were being medicated for attention deficit hyperactivity disorder had poorer outcomes on a wide range of measures compared with others in the study (N=766,244). The outcomes included: poor academic attainment, unauthorized absence from...Read More

A study in The Journal of Child Psychology and Psychiatry last month reported that”extended use of medication [for ADHD] was associated with suppression of adult height but not with reduction of symptom severity.” So basically, it stunts growth and it isn’t effective. So why isn’t there a bigger hue and cry about this? There are...Read More

There’s a news feature in the New York Times today (“Drowned in a Stream of Prescriptions”)  that focuses on the problem of addiction to ADHD medications.  While the article deals mainly with college students and young adults who deceive mental health professionals into thinking they have ADHD so that they can receive these highly addictive...Read More

A new study reported in The Journal of Pediatrics, reports that exercise may benefit children with ADHD.  In this study, kids with ADHD were matched with a same-age, same-socio-economic status group of “normal” children.  The groups engaged in two experimental conditions:  one day then engaged in 20 minutes of quiet reading, and the next day...Read More